切换至 "中华医学电子期刊资源库"
高级检索
中华眼科医学杂志(电子版)

中华眼科医学杂志(电子版) ›› 2022, Vol. 12 ›› Issue (04) : 237 -241. doi: 10.3877/cma.j.issn.2095-2007.2022.04.009

综述

选择性激光小梁成形术的研究进展
师宜鹏1, 孙文英2, 谢立科3, 解晓斌4,†()   
  1. 1. 100040　北京，中国中医科学院眼科医院2020级硕士研究生
    2. 100040　北京，中国中医科学院眼科医院2021级硕士研究生
    3. 100040　北京，中国中医科学院眼科医院眼底病与眼外伤专科
    4. 100040　北京，中国中医科学院眼科医院青光眼专科
  • 收稿日期:2021-08-11 出版日期:2022-08-28
  • 通信作者: 解晓斌
  • 基金资助:
    首都临床特色应用研究(Z181100001718086)

Advances on selective laser trabeculoplasty

Yipeng Shi1, Wenying Sun2, Like Xie3, Xiaobin Xie4,†()   

  1. 1. Master′s degree 2020, Eye Hospital of China Academy of Chinese Medical Sciences, Beijing 100040, China
    2. Master′s degree 2021, Eye Hospital of China Academy of Chinese Medical Sciences, Beijing 100040, China
    3. Department of Ocular Fundus Disease and Ocular Trauma, Eye Hospital of China Academy of Chinese Medical Sciences, Beijing 100040, China
    4. Department of Glaucoma, Eye Hospital of China Academy of Chinese Medical Sciences, Beijing 100040, China
  • Received:2021-08-11 Published:2022-08-28
  • Corresponding author: Xiaobin Xie
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

师宜鹏, 孙文英, 谢立科, 解晓斌. 选择性激光小梁成形术的研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(04): 237-241.

Yipeng Shi, Wenying Sun, Like Xie, Xiaobin Xie. Advances on selective laser trabeculoplasty[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(04): 237-241.

青光眼是全球第一大不可逆的致盲性眼病，通过药物、激光和手术降低眼压是治疗青光眼的基本方法。选择性激光小梁成形术(SLT)是应用倍频Q开关、波长532 nm的掺钕钇铝石榴石激光，选择性作用于色素性小梁组织达到降低眼压目的。近30年来，SLT在不引起小梁网凝固性损伤的情况下可以降低眼压，已经逐渐成为治疗以原发性开角型青光眼为主的各种类型青光眼的初始治疗或替代治疗方法之一。本文中笔者就SLT的历史沿革、降眼压机制、临床应用、初始治疗、重复治疗、治疗成功的预测因素、并发不良反应、成本效益及健康相关生活质量等方面进行综述。

关键词: 选择性激光小梁成形术, 青光眼, 眼压, 小梁网

Glaucoma is the leading cause of irreversible blindness in the whole world. The basic treatment methods for glaucoma are concentrated on the intraocular pressure reduction by medication, laser and surgery. Selective laser trabeculectomy (SLT) is performed by using a Q-switched, frequency-doubled Nd: YAG laser at 532 nm wave length, which selectively acts on pigmentary trabecular tissue to reduce intraocular pressure. Over the past three decades, it has been demonstrated that SLT has become a safe and effective option of the alternative or initial treatments for various types of glaucoma, mainly primary open-angle glaucoma, because of intraocular pressure reduction with absent or minimal structural damage to the trabecular meshwork. The history of SLT, mechanisms of action, clinical application, initial treatment, repeat treatment, predictive factors of treatment success, complications and adverse reactions, cost-effectiveness, and health-related quality of life were reviewed in this paper.

Key words: Selective laser trabeculoplasty, Glaucoma, Intraocular pressure, Trabecular meshwork
[1]
Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040[J]. Ophthalmology, 2014, 121(11): 2081－2090.
[2]
Gazzard G, Konstantakopoulou E, Garway－Heath D, et al. Selective laser trabeculoplasty versus eye drops for first－line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial[J]. Lancet, 2019, 393(10180): 1505－1516.
[3]
Krasnov MM. Laseropuncture of anterior chamber angle in glaucoma[J]. Am J Ophthalmol, 1973, 75(4): 674－678.
[4]
Wise JB, Witter SL. Argon laser therapy for open－angle glaucoma. A pilot study[J]. Arch Ophthalmol, 1979, 97(2): 319－322.
[5]
Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation[J]. Science, 1983, 220(4596): 524－527.
[6]
Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions[J]. Exp Eye Res, 1995, 60(4): 359－371.
[7]
Latina MA, Sibayan SA, Shin DH, et al. Q－switched 532－nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study[J]. Ophthalmology, 1998, 105(11): 2082－2090.
[8]
谭海波，祝丽娜，沈洁. 选择性激光小梁成形术联合药物治疗在开角型青光眼中的应用[J]. 上海交通大学学报(医学版)，2015，35(12)：1858－1861，1866.
[9]
张洪洋，叶一明，杨扬帆，等. 选择性激光小梁成形术的激光效应对体外小梁细胞MMP－3及MMP－9表达的影响[J]. 中华实验眼科杂志，2015，33(3)：227－231.
[10]
Lee JW, Wong MO, Liu CC, et al. Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open－angle glaucoma[J]. J Glaucoma, 2015, 24(5): e128－131.
[11]
Nirappel A, Klug E, Ye R, et al. Effectiveness of Selective Laser Trabeculoplasty Applied to 360° vs 180° of the Angle[J]. J Ophthalmol, 2021: 8860601.
[12]
Shibata M, Sugiyama T, Ishida O, et al. Clinical results of selective laser trabeculoplasty in open－angle glaucoma in Japanese eyes: comparison of 180 degree with 360 degree SLT[J]. J Glaucoma, 2012, 21(1): 17－21.
[13]
Prasad N, Murthy S, Dagianis JJ, et al. A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension[J]. J Glaucoma, 2009, 18(2): 157－160.
[14]
European Glaucoma Society Terminology Guidelines for Glaucoma, 5th Edition[J]. Br J Ophthalmol. 2021, 105(Suppl 1): 1－169.
[15]
Francis BA, Loewen N, Hong B, et al. Repeatability of selective laser trabeculoplasty for open－angle glaucoma[J]. BMC Ophthalmol, 2016, 16: 128.
[16]
Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives[J]. Clin Ophthalmol, 2015, 9: 833－841.
[17]
Lee JW, Ho WL, Chan JC, et al. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results[J]. BMC Ophthalmol, 2015, 15: 1.
[18]
Pillunat KR, Spoerl E, Elfes G, et al. Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy[J]. Acta Ophthalmol, 2016, 94(7): 692－696.
[19]
Raj S, Tigari B, Faisal TT, et al. Efficacy of selective laser trabeculoplasty in primary angle closure disease[J]. Eye (Lond), 2018, 32(11): 1710－1716.
[20]
Aljasim LA, Owaidhah O, Edward DP. Selective Laser Trabeculoplasty in Primary Angle－closure Glaucoma After Laser Peripheral Iridotomy: A Case－Control Study[J]. J Glaucoma, 2016, 25(3): e253－258.
[21]
Lindegger DJ, Funk J, Jaggi GP. Long－term effect of selective laser trabeculoplasty on intraocular pressure in pseudoexfoliation glaucoma[J]. Klin Monbl Augenheilkd, 2015, 232(4): 405－408.
[22]
Kara N, Altan C, Yuksel K, et al. Comparison of the efficacy and safety of selective laser trabeculoplasty in cases with primary open－angle glaucoma and pseudoexfoliative glaucoma[J]. Kaohsiung J Med Sci, 2013, 29(9): 500－504.
[23]
Ilveskoski L, Taipale C, Tuuminen R. Selective laser trabeculoplasty in exfoliative glaucoma eyes with prior argon laser trabeculoplasty[J]. Acta Ophthalmol, 2020, 98(1): 58－64.
[24]
Ayala M. Long－term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients[J]. J Glaucoma, 2014, 23(9): 616－619.
[25]
Xiao J, Zhao C, Liang A, et al. Efficacy and Safety of High－Energy Selective Laser Trabeculoplasty for Steroid－Induced Glaucoma in Patients with Quiescent Uveitis[J]. Ocul Immunol Inflamm, 2020: 1－5.
[26]
Bozkurt E, Kara N, Yazici AT, et al. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection[J]. Am J Ophthalmol, 2011, 152(6): e972, e976－e981.
[27]
Zhang M, Li B, Wang J, et al. Clinical results of selective laser trabeculoplasty in silicone oil－induced secondary glaucoma[J]. Graefes Arch Clin Exp Ophthalmol, 2014, 252(6): 983－987.
[28]
张伟，谭海波. 选择性激光小梁成形术治疗硅油填充眼继发性青光眼[J]. 国际眼科杂志，2019，19(7)：1215－1217.
[29]
Nagar M, Ogunyomade A, O'Brart DP, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma[J]. Br J Ophthalmol, 2005, 89(11): 1413－1417.
[30]
Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty[J]. Br J Ophthalmol, 2009, 93(4): 497－501.
[31]
Kiddee W, Atthavuttisilp S. The effects of selective laser trabeculoplasty and travoprost on circadian intraocular pressure fluctuations: A randomized clinical trial[J]. Medicine (Baltimore), 2017, 96(6): e6047.
[32]
Ang GS, Fenwick EK, Constantinou M, et al. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial[J]. Br J Ophthalmol, 2020, 104(6): 813－821.
[33]
Chi SC, Kang YN, Hwang DK, et al. Selective laser trabeculoplasty versus medication for open－angle glaucoma: systematic review and meta－analysis of randomised clinical trials[J]. Br J Ophthalmol, 2020, 104(11): 1500－1507.
[34]
Li X, Wang W, Zhang X. Meta－analysis of selective laser trabeculoplasty versus topical medication in the treatment of open－angle glaucoma[J]. BMC Ophthalmol, 2015, 15: 107.
[35]
Pahlitzsch M, Davids AM, Winterhalter S, et al. Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First－Step Procedure in Selected Patients with Open－Angle Glaucoma[J]. Ophthalmol Ther, 2021, 10(3): 509－524.
[36]
Fea AM, Ahmed II, Lavia C, et al. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma[J]. Clin Exp Ophthalmol, 2017, 45(2): 120－127.
[37]
Katz LJ, Steinmann WC, Kabir A, et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial[J]. J Glaucoma, 2012, 21(7): 460－468.
[38]
Lai JS, Chua JK, Tham CC, et al. Five－year follow up of selective laser trabeculoplasty in Chinese eyes[J]. Clin Exp Ophthalmol, 2004, 32(4): 368－372.
[39]
Wright DM, Konstantakopoulou E, Montesano G, et al. Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)[J]. Ophthalmology, 2020, 127(10): 1313－1321.
[40]
Durr GM, Harasymowycz P. The effect of repeat 360－degree selective laser trabeculoplasty on intraocular pressure control in open－angle glaucoma[J]. J Fr Ophtalmol, 2016, 39(3): 261－264.
[41]
Garg A, Vickerstaff V, Nathwani N, et al. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication－Naive Open－Angle Glaucoma and Ocular Hypertension during the LiGHT Trial[J]. Ophthalmology, 2020, 127(4): 467－476.
[42]
Polat J, Grantham L, Mitchell K, et al. Repeatability of selective laser trabeculoplasty[J]. Br J Ophthalmol, 2016, 100(10): 1437－1441.
[43]
Elahi S, Rao HL, Dumitru A, et al. Predictors of Success in Selective Laser Trabeculoplasty: Data From the Lausanne Laser Trabeculoplasty Registry[J]. J Glaucoma, 2020, 29(7): 550－555.
[44]
Gracner T, Naji M, Hudovernik M, et al. Predictive factors of successful selective laser trabeculoplasty in open－angle glaucoma[J]. Klin Monbl Augenheilkd, 2007, 224(12): 922－926.
[45]
Lee JW, Liu CC, Chan J, et al. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese[J]. Clin Ophthalmol, 2014, 8: 1787－1791.
[46]
Bruen R, Lesk MR, Harasymowycz P. Baseline Factors Predictive of SLT Response: A Prospective Study[J]. J Ophthalmol, 2012: 642869.
[47]
Shazly TA, Latina MA, Dagianis JJ, et al. Effect of central corneal thickness on the long－term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open－angle glaucoma[J]. Cornea, 2012, 31(8): 883－886.
[48]
Kennedy JB, SooHoo JR, Kahook MY, et al. Selective Laser Trabeculoplasty: An Update[J]. Asia Pac J Ophthalmol (Phila), 2016, 5(1): 63－69.
[49]
Phillis CA, Bourke RD. Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty[J]. J Glaucoma, 2016, 25(2): e110－e114.
[50]
Knickelbein JE, Singh A, Flowers BE, et al. Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty[J]. J Cataract Refract Surg, 2014, 40(10): 1731－1735.
[51]
Berdahl JP, Khatana AK, Katz LJ, et al. Cost－comparison of two trabecular micro－bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open－angle glaucoma[J]. J Med Econ, 2017, 20(7): 760－766.
[52]
Schultz NM, Wong WB, Coleman AL, et al. Predictors, Resource Utilization, and Short－term Costs of Laser Trabeculoplasty Versus Medication Management in Open－Angle Glaucoma[J]. Am J Ophthalmol, 2016, 168: 78－85.
[53]
Choi JA, Song LD, Choi S, et al. The cost－effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open－angle glaucoma in South Korea[J]. Medicine (Baltimore), 2019, 98(2): e14026.
[54]
Keyser MD, Belder MD, Groot VD. Quality of life in glaucoma patients after selective laser trabeculoplasty[J]. Int J Ophthalmol, 2017, 10(5): 742－748.
[55]
Zhou R, Sun Y, Chen H, et al. Laser Trabeculoplasty for Open－Angle Glaucoma: A Systematic Review and Network Meta－Analysis[J]. Am J Ophthalmol, 2021, 229: 301－313.
[1] 曾舒涵, 庾楠楠, 应道静, 陈丽植, 容丽萍, 莫樱, 蒋小云. 激素敏感型原发性肾病综合征患儿激素治疗巩固维持阶段不同减量方案比较[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 468-475.
[2] 蔡紫妍, 段宣初, 杨翔. 深度学习算法在青光眼筛查与诊断中应用的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 188-192.
[3] 张小艳, 郝晓凤, 谢立科. 眼缺血综合征的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 183-187.
[4] 杨蕾, 刘姗姗, 范晓军, 王一涵, 张燕妮, 徐嘉轶, 王继兵. 自制眼内前房角镜－分离器行前房角分离联合超声乳化白内障吸除及后房型人工晶状体植入术治疗原发性闭角型青光眼的临床研究[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 140-145.
[5] 冷玥祺, 廖衍沣, 武歆纯, 李美瑶, 石逸雯, 王晋豪, 杨嘉瑞, 李学民. 环境因素对眼部生理与病理影响的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 109-113.
[6] 崔宏宇, 杨一佺, 郭黎霞, 吕爱国, 张志宏, 张新, 杨艳萍, 申然, 连丽英, 曹志刚, 王立芳, 胡建华, 范肃洁. 改良Ahmed青光眼引流阀植入术治疗闭角期新生血管性青光眼疗效的临床研究[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 76-81.
[7] 李茹月, 庞睿奇, 王宁利. 血脂异常与原发性开角型青光眼发病相关性的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(01): 35-39.
[8] 金杉杉, 熊琨, 王璐, 梁远波. 中国青光眼流行趋势及特征的Meta分析[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 332-340.
[9] 桑青, 辛晨, 王瑾, 毛迎燕, 杨迪亚, 牟大鹏, 张烨, 王怀洲, 王宁利. 新型微创内路三联手术后房水外流泵功能变化的临床研究[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 326-331.
[10] 王柠, 王佳伟, 刘旭阳. 重视眼颅压力差在多学科领域的应用[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 321-325.
[11] 程英, 安文在, 林丹婷, 王宁利. 肠道菌群与眼部常见疾病关系的研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(05): 305-309.
[12] 王震宇, 张维嘉, 胡曼, 高传文, 石砚, 王怀洲. 微导管辅助360°小梁切开术治疗先天性白内障术后继发青光眼的临床研究[J]. 中华眼科医学杂志(电子版), 2022, 12(05): 275-280.
[13] 雷蕊莲, 赵军梅, 唐桂兰. 微导管辅助微创青光眼手术研究的新进展[J]. 中华眼科医学杂志(电子版), 2022, 12(03): 178-182.
[14] 高琪, 汪晓娟, 冯婧, 陶勇. 房水检测在青光眼睫状体炎综合征诊断中应用的临床研究[J]. 中华眼科医学杂志(电子版), 2022, 12(02): 70-75.
[15] 王英明, 殷雪, 任亚璐, 张晓峰. 青光眼患者常用大剂量滴眼液微生物污染情况的临床研究[J]. 中华眼科医学杂志(电子版), 2021, 11(06): 359-364.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号